Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia– a case series
Abstract Background 80% of patients value information on treatment options as an important part of recovery, further patients with a history of psychotic episodes feel excluded from decision making about their antipsychotic treatment, and on top of that, mental health staff is prone to be reluctant...
Main Authors: | Sofie Norlin Mølgaard, Mette Ødegaard Nielsen, Kickan Roed, Jimmi Nielsen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12888-024-05699-y |
Similar Items
-
Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR
by: Anne Emilie Stürup, et al.
Published: (2022-07-01) -
Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose
by: Chen-Chung Liu, et al.
Published: (2023-01-01) -
TAILOR – tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial
by: Anne Emilie Stürup, et al.
Published: (2017-09-01) -
Efficacy and Tolerance of Antipsychotics Used for the Treatment of Patients Newly Diagnosed with Schizophrenia: A Systematic Review and Meta-Analysis
by: Zina Sherzad Qadir, et al.
Published: (2023-11-01) -
Assessment of hospitalizations in schizophrenia patients treated with paliperidone 1-monthly (PP1M), paliperidone 3-monthly (PP3M), aripiprazole once-monthly (AOM) and other oral antipsychotics (OAP) in clinical practice
by: L. Gutiérrez Rojas, et al.
Published: (2021-04-01)